Immunology pipeline
The latest news about Immunology pipeline: headlines, AI summaries and the full story from every source.
- AbbVie Acquires Apogee Therapeutics for $10.9 Billion to Bolster Immunology and Oncology Portfolios
- Biogen Acquires RayThera to Bolster Immunology Portfolio Amid Shifting Financial Dynamics
- AbbVie Announces Acquisition of Apogee Therapeutics for $10.9 Billion
- AbbVie Near Acquisition of Apogee Therapeutics in $11B Deal
- AbbVie Acquires Apogee Therapeutics for $10.9 Billion to Bolster Immunology Portfolio